E0676 DVT Prevention Devices: Payer Documentation and Compliance Guide

DVT Prevention Devices, E0676, and Payer Documentation: What ASCs and DME Partners Need to Know

How providers, surgery centers, and DME organizations can prepare for payer-specific coverage and documentation review

The payer environment surrounding post-surgical DVT prevention devices has become more complex. For ambulatory surgery centers, physicians, and DME suppliers, the issue is no longer just whether a pneumatic compression device is clinically appropriate. It is also whether the device, diagnosis, site of service, payer policy, documentation, and billing workflow all align before a claim is submitted.

This is especially important when discussing HCPCS code E0676, which describes an intermittent limb compression device used for the prevention of deep venous thrombosis. Medicare coding guidance identifies E0676 as the only HCPCS code for pneumatic compression devices used for DVT prevention and states that the code is all-inclusive, meaning accessories and related components generally should not be billed separately at the time of initial issue. [Source 2]

However, coverage for DVT prevention devices varies significantly by payer. Medicare guidance treats E0676 devices used for prevention of venous thromboembolism as preventive and excluded from the Medicare DME benefit. As a result, E0676 claims may be statutorily denied as no Medicare benefit, regardless of whether the device appears clinically reasonable for a particular patient. [Source 2]

That distinction matters. Documentation quality is essential, but documentation alone does not create coverage when a payer policy excludes the device or service.

Why payer review is increasing

Payers continue to focus on reducing improper payments, confirming medical necessity, and verifying that billed services meet coverage criteria. Pneumatic compression devices remain an area of payer attention because documentation and medical-necessity issues continue to drive claim denials and improper payments.

CMS reported a 61.5% improper payment rate for pneumatic compression devices in the 2024 Medicare Fee-for-Service Supplemental Improper Payment Data, with insufficient documentation and medical necessity identified as the denial reasons. [Source 3]

For providers and DME suppliers, this means payer review may focus on more than whether a device was dispensed. Reviewers may evaluate whether the documentation clearly supports the billed code, whether the patient meets the applicable coverage criteria, whether the physician order is complete, whether proof of delivery exists, and whether the clinical record supports the claim. [Source 3]

Medicare and commercial payer rules are not the same

A major compliance risk in DVT prevention programs is assuming that all payers treat E0676 the same way. They do not.

Medicare’s National Coverage Determination for pneumatic compression devices covers pneumatic devices for the treatment of lymphedema or chronic venous insufficiency with venous stasis ulcers, subject to specific criteria and physician oversight. [Source 1]

For DVT prevention, Medicare coding guidance takes a different position. It states that a pneumatic compression device used for prevention of venous thromboembolism under E0676 is a preventive service and is excluded from coverage under the Medicare DME benefit. [Source 2]

Commercial payer policies may differ. For example, UnitedHealthcare’s commercial policy states that intermittent limb compression devices may be proven and medically necessary in certain circumstances for the prevention of DVT when applicable medical-necessity criteria are met. [Source 4]

Other commercial policies may be more restrictive. Anthem’s clinical guideline states that the use of pneumatic compression devices in the home setting for prevention of venous thromboembolism of the extremities is considered not medically necessary for all indications. [Source 5]

This variation is why payer-specific verification is essential before dispensing, billing, or advising patients about expected coverage.

What payer documentation may need to support

For payers that do cover post-surgical DVT prevention devices under certain conditions, documentation should be complete, consistent, and available before claim submission.

Depending on the payer and plan, documentation may need to support:

Patient risk assessment

The medical record should identify the clinical factors supporting elevated DVT or VTE risk. This may include the procedure type, mobility limitations, bleeding risk, contraindications to pharmacologic prophylaxis, prior history, and other relevant clinical factors.

Medical necessity

The physician’s rationale should explain why the device is appropriate for the patient, not just that the device was ordered. CMS guidance for covered pneumatic compression devices emphasizes physician evaluation, medical-necessity determination, treatment plan, patient instruction, and ongoing monitoring. [Source 1]

Physician order and treatment plan

The order and treatment plan should be complete and consistent with payer requirements. CMS compliance guidance notes that physician oversight may include evaluating the patient’s condition, instructing the patient on device operation, defining pressure, frequency, and duration of use, and monitoring response to treatment. [Source 3]

Coding accuracy

The submitted code should match the device and intended use. E0676 is specifically used for intermittent limb compression devices for DVT prevention and is considered all-inclusive for accessories at the time of initial issue. [Source 2]

Proof of delivery and patient education

DME suppliers should maintain proof of delivery and documentation showing that the patient received appropriate instructions. PDAC guidance identifies proof of delivery as part of the general documentation requirements for DMEPOS payment support. [Source 2]

Clinical consistency across records

The claim, physician order, operative note, diagnosis coding, risk assessment, and patient file should tell the same story. Inconsistencies between records can increase denial risk, even when the device was clinically appropriate.

Common operational risks for DVT prevention programs

DVT prevention programs can run into reimbursement or compliance issues when the workflow is not payer-specific. Common risks include:

• Treating Medicare and commercial coverage rules as interchangeable
• Dispensing a device before confirming payer-specific coverage criteria
• Relying on a generic physician order without a clear clinical rationale
• Missing proof of delivery or patient instruction documentation
• Billing accessories separately when they are included in the E0676 code
• Submitting claims without reviewing whether the payer considers home-use DVT prevention devices medically necessary
• Assuming documentation can fix a statutory exclusion or payer non-coverage policy

The safest approach is to treat every claim as payer-specific from the beginning.

What ASCs, providers, and DME suppliers should do now

Organizations that want to operate successful DVT prevention programs should focus on three areas: coverage verification, documentation quality, and audit-ready workflows.

1. Verify payer policy before dispensing

Before a device is provided, teams should confirm the applicable payer policy, plan language, prior authorization requirements, and medical-necessity criteria.

For Medicare beneficiaries, teams should be especially careful with E0676 because Medicare guidance states that E0676 used for prevention of venous thromboembolism is excluded from the Medicare DME benefit. [Source 2]

For commercial plans, teams should verify the specific plan policy because coverage may vary significantly across payers and benefit designs. [Sources 4, 5]

2. Strengthen documentation workflows

Documentation should be collected and reviewed before claim submission whenever possible. The file should clearly support the patient’s risk profile, physician rationale, order, device delivery, patient education, and coding.

CMS compliance guidance shows that insufficient documentation and medical necessity are common reasons for improper payments involving pneumatic compression devices. [Source 3]

3. Build internal quality review before billing

DME suppliers and provider partners should consider a pre-submission review process for DVT prevention claims. This review can help confirm that the file includes required documentation, the claim matches the device and payer policy, and the record is internally consistent.

4. Separate Medicare workflows from commercial workflows

Because Medicare and commercial payer rules may differ, teams should avoid a single generic workflow for every patient. Medicare-specific exclusions, commercial payer criteria, prior authorization rules, and plan-specific requirements should be built into the operational process.

5. Maintain audit-ready patient files

Every patient file should be organized so that it can respond to payer review without major post-submission reconstruction. This includes the order, medical record support, operative or treatment documentation where applicable, proof of delivery, patient education, and billing details.

How Nexara Health is responding

At Nexara Health, we recognize that DVT prevention programs require more than device access. They require payer-aware workflows, documentation discipline, and operational processes that support providers, surgery centers, DME partners, and patients.

Our ASC DVT Solutions platform is being developed to help healthcare partners navigate the increasing complexity surrounding DVT prevention, documentation, reimbursement, and compliance.

That means helping organizations think through:

• Payer-specific coverage requirements
• Documentation collection and review
• Physician order consistency
• Patient education and delivery verification
• Internal quality checks before claim submission
• Audit-ready file organization

As payer oversight continues to evolve, the organizations best positioned to succeed will be those that build compliant, transparent, and payer-specific workflows from the beginning.

Sources

Source 1 — CMS National Coverage Determination 280.6: Pneumatic Compression Devices
Use this for Medicare coverage criteria related to lymphedema and chronic venous insufficiency with venous stasis ulcers, plus physician oversight and medical-necessity documentation. CMS states pneumatic devices are covered for lymphedema or CVI with venous stasis ulcers and outlines physician oversight requirements.

Source 2 — PDAC / Joint DME MAC: Pneumatic Compression Devices — Correct Coding and Billing — Revised
Use this for the key E0676 compliance language. PDAC states E0676 is the only HCPCS code for PCDs used for prevention of DVT, that it is all-inclusive, and that E0676 for prevention of venous thromboembolism is treated as preventive and statutorily denied as no Medicare benefit.

Source 3 — CMS Medicare Provider Compliance Tips: Pneumatic Compression Devices & Accessories
Use this for the improper payment rate and denial reasons. CMS reports a 61.5% improper payment rate for pneumatic compression devices in the 2024 Medicare FFS supplemental data, with insufficient documentation and medical necessity as the denial reasons.

Source 4 — UnitedHealthcare Commercial and Individual Exchange Medical Policy: Pneumatic Compression Devices
Use this to show that some commercial payers may consider intermittent limb compression devices medically necessary for DVT prevention when criteria are met. UHC’s 2026 commercial policy says intermittent limb compression devices are proven and medically necessary in certain circumstances for DVT prevention when InterQual criteria are met.

Source 5 — Anthem Clinical UM Guideline CG-DME-46
Use this to show payer variation. Anthem’s guideline says home-use pneumatic compression devices for prevention of venous thromboembolism are considered not medically necessary for all indications.

Final note

This article is for educational purposes only and does not constitute legal, billing, coding, reimbursement, or medical advice. Coverage and reimbursement vary by payer, plan, patient condition, site of service, documentation, and applicable law. Providers, ASCs, and DME suppliers should consult payer policies, compliance professionals, legal counsel, and qualified billing experts before making coverage or billing decisions.